GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » EBITDA Margin %

Autobio Diagnostics Co (SHSE:603658) EBITDA Margin % : 33.80% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Autobio Diagnostics Co's EBITDA for the three months ended in Mar. 2024 was ¥368 Mil. Autobio Diagnostics Co's Revenue for the three months ended in Mar. 2024 was ¥1,089 Mil. Therefore, Autobio Diagnostics Co's EBITDA margin for the quarter that ended in Mar. 2024 was 33.80%.


Autobio Diagnostics Co EBITDA Margin % Historical Data

The historical data trend for Autobio Diagnostics Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co EBITDA Margin % Chart

Autobio Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.07 39.46 39.18 39.34 41.38

Autobio Diagnostics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.58 32.10 35.64 30.24 33.80

Competitive Comparison of Autobio Diagnostics Co's EBITDA Margin %

For the Medical Devices subindustry, Autobio Diagnostics Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's EBITDA Margin % falls into.



Autobio Diagnostics Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Autobio Diagnostics Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1838.693/4443.656
=41.38 %

Autobio Diagnostics Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=368.16/1089.195
=33.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Autobio Diagnostics Co  (SHSE:603658) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Autobio Diagnostics Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Autobio Diagnostics Co (SHSE:603658) Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines